BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 24972180)

  • 1. Large-scale proteome quantification of hepatocellular carcinoma tissues by a three-dimensional liquid chromatography strategy integrated with sample preparation.
    Xu B; Wang F; Song C; Sun Z; Cheng K; Tan Y; Wang H; Zou H
    J Proteome Res; 2014 Aug; 13(8):3645-54. PubMed ID: 24972180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Super-SILAC mix coupled with SIM/AIMS assays for targeted verification of phosphopeptides discovered in a large-scale phosphoproteome analysis of hepatocellular carcinoma.
    Lin YT; Chien KY; Wu CC; Chang WY; Chu LJ; Chen MC; Yeh CT; Yu JS
    J Proteomics; 2017 Mar; 157():40-51. PubMed ID: 28192239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improvement of the quantification accuracy and throughput for phosphoproteome analysis by a pseudo triplex stable isotope dimethyl labeling approach.
    Song C; Wang F; Ye M; Cheng K; Chen R; Zhu J; Tan Y; Wang H; Figeys D; Zou H
    Anal Chem; 2011 Oct; 83(20):7755-62. PubMed ID: 21902226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In situ sample processing approach (iSPA) for comprehensive quantitative phosphoproteome analysis.
    Huang J; Qin H; Dong J; Song C; Bian Y; Dong M; Cheng K; Wang F; Sun D; Wang L; Ye M; Zou H
    J Proteome Res; 2014 Sep; 13(9):3896-904. PubMed ID: 25072903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of human hepatocellular carcinoma-related biomarkers by two-dimensional difference gel electrophoresis and mass spectrometry.
    Lee IN; Chen CH; Sheu JC; Lee HS; Huang GT; Yu CY; Lu FJ; Chow LP
    J Proteome Res; 2005; 4(6):2062-9. PubMed ID: 16335951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphoproteome analysis of the human Chang liver cells using SCX and a complementary mass spectrometric strategy.
    Sui S; Wang J; Yang B; Song L; Zhang J; Chen M; Liu J; Lu Z; Cai Y; Chen S; Bi W; Zhu Y; He F; Qian X
    Proteomics; 2008 May; 8(10):2024-34. PubMed ID: 18491316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive phosphoproteome analysis of INS-1 pancreatic β-cells using various digestion strategies coupled with liquid chromatography-tandem mass spectrometry.
    Han D; Moon S; Kim Y; Ho WK; Kim K; Kang Y; Jun H; Kim Y
    J Proteome Res; 2012 Apr; 11(4):2206-23. PubMed ID: 22276854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential proteomic analysis of hepatocellular carcinoma.
    Corona G; De Lorenzo E; Elia C; Simula MP; Avellini C; Baccarani U; Lupo F; Tiribelli C; Colombatti A; Toffoli G
    Int J Oncol; 2010 Jan; 36(1):93-9. PubMed ID: 19956837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative proteomics reveal up-regulated protein expression of the SET complex associated with hepatocellular carcinoma.
    Li C; Ruan HQ; Liu YS; Xu MJ; Dai J; Sheng QH; Tan YX; Yao ZZ; Wang HY; Wu JR; Zeng R
    J Proteome Res; 2012 Feb; 11(2):871-85. PubMed ID: 22082227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and quantitation of signal molecule-dependent protein phosphorylation.
    Groen A; Thomas L; Lilley K; Marondedze C
    Methods Mol Biol; 2013; 1016():121-37. PubMed ID: 23681576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A fully automated system with online sample loading, isotope dimethyl labeling and multidimensional separation for high-throughput quantitative proteome analysis.
    Wang F; Chen R; Zhu J; Sun D; Song C; Wu Y; Ye M; Wang L; Zou H
    Anal Chem; 2010 Apr; 82(7):3007-15. PubMed ID: 20230046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abundance-ratio-based semiquantitative analysis of site-specific N-linked glycopeptides present in the plasma of hepatocellular carcinoma patients.
    Lee HJ; Cha HJ; Lim JS; Lee SH; Song SY; Kim H; Hancock WS; Yoo JS; Paik YK
    J Proteome Res; 2014 May; 13(5):2328-38. PubMed ID: 24628331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In Vivo Phosphoproteome Analysis Reveals Kinome Reprogramming in Hepatocellular Carcinoma.
    Ren L; Li C; Wang Y; Teng Y; Sun H; Xing B; Yang X; Jiang Y; He F
    Mol Cell Proteomics; 2018 Jun; 17(6):1067-1083. PubMed ID: 29472430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphoproteomic analysis of the highly-metastatic hepatocellular carcinoma cell line, MHCC97-H.
    Tian M; Cheng H; Wang Z; Su N; Liu Z; Sun C; Zhen B; Hong X; Xue Y; Xu P
    Int J Mol Sci; 2015 Feb; 16(2):4209-25. PubMed ID: 25690035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nano-LC-MS/MS based proteomics of hepatocellular carcinoma cells compared to Chang liver cells and tanshinone IIA induction.
    Long X; Zhang J; Zhang Y; Yao J; Cai Z; Yang P
    Mol Biosyst; 2011 May; 7(5):1728-41. PubMed ID: 21423987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased expression and phosphorylation of liver glutamine synthetase in well-differentiated hepatocellular carcinoma tissues from patients infected with hepatitis C virus.
    Kuramitsu Y; Harada T; Takashima M; Yokoyama Y; Hidaka I; Iizuka N; Toda T; Fujimoto M; Zhang X; Sakaida I; Okita K; Oka M; Nakamura K
    Electrophoresis; 2006 Apr; 27(8):1651-8. PubMed ID: 16609938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A strategy for large-scale phosphoproteomics and SRM-based validation of human breast cancer tissue samples.
    Narumi R; Murakami T; Kuga T; Adachi J; Shiromizu T; Muraoka S; Kume H; Kodera Y; Matsumoto M; Nakayama K; Miyamoto Y; Ishitobi M; Inaji H; Kato K; Tomonaga T
    J Proteome Res; 2012 Nov; 11(11):5311-22. PubMed ID: 22985185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification by differential tissue proteome analysis of talin-1 as a novel molecular marker of progression of hepatocellular carcinoma.
    Kanamori H; Kawakami T; Effendi K; Yamazaki K; Mori T; Ebinuma H; Masugi Y; Du W; Nagasaka K; Ogiwara A; Kyono Y; Tanabe M; Saito H; Hibi T; Sakamoto M
    Oncology; 2011; 80(5-6):406-15. PubMed ID: 21846996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expression and clinical significance of anti-apoptotic factors PED/PEA-15 and XIAP in hepatocellular carcinoma].
    Sun DG; Wu YF; Gao ZM; Liang R; Wang LM
    Zhonghua Yi Xue Za Zhi; 2010 Jun; 90(24):1660-4. PubMed ID: 20979872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical proteomics: liquid chromatography-mass spectrometry purification systems.
    Henry M; Meleady P
    Methods Mol Biol; 2011; 681():473-83. PubMed ID: 20978984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.